About: Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1982

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1982 (uk) im November 1982 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1982 (en) artículu científicu espublizáu en payares de 1982 (ast)
publication date	wds:Q71438258-B5E48C9A-BA4C-4D35-944F-BB8FC2CC2383
publication date	1982-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71438258-3CC1B6A8-4996-427F-B155-9BC8FB16824F
language of work or name	English
author name string	wds:Q71438258-2D197395-3A68-431C-95A2-FCEF92952D37 wds:Q71438258-35B7246B-1C25-4144-9D92-6BEAB3B5AE12 wds:Q71438258-46537280-2E6E-46DB-9EAF-93CD00AD1D8B wds:Q71438258-46C645CB-BFA9-4346-B20C-103B80B13A8A wds:Q71438258-5FEBDD20-7C57-49B7-A4AA-089AE538D1D0 wds:Q71438258-D4C2FAE7-B5F7-462A-B610-72AE2E53696D
author name string	D J Slymen J O Armitage M P Corder C E Platz F R Dick S C Garneau
rdfs:label	Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) (en) Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) (nl)
skos:prefLabel	Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) (en) Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) (nl)
name	Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) (en) Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) (nl)
title	wds:Q71438258-F66D01E2-10C2-4D97-B38A-65AFFA453408
title	Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) (en)
page(s)	wds:Q71438258-4F7EB160-7F2D-4FEF-B240-E9D6FC772559
page(s)	1695-1702
instance of	wds:Q71438258-B528D78B-1ADD-4DE6-915D-13BCEE79A7A1
instance of	scholarly article
main subject	wds:Q71438258-7B26B87A-2C6C-4F96-B454-F7FF3FC3F7E7 wds:Q71438258-F7810CC0-CBE7-4511-B39E-2B3F4B45AAD3
main subject	wd:Q18936 large-cell lymphoma
PubMed ID	wds:Q71438258-235C7703-3611-4393-9C2C-1589D3841112
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6749279
PubMed ID	6749279
published in	wds:Q71438258-F6CF89F2-EB6B-4BE0-8110-67C5E90F52BD
published in	Cancer
issue	wds:Q71438258-35D25B86-6E7A-4CA8-BC29-09AF0938A399
volume	wds:Q71438258-17A14A8F-86BB-4A63-A2EE-5277D82DD25D
issue	9
volume	50
DOI	wds:Q71438258-5CCB5EB4-06EB-4A70-AF97-AF396388BBB3
DOI	http://dx.doi.org/10.1002/1097-0142(19821101)50:9%3C1695::AID-CNCR2820500907%3E3.0.CO;2-H
DOI	10.1002/1097-0142(19821101)50:9<1695::AID-CNCR2820500907>3.0.CO;2-H
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71438258
is cites work of	Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age Allogeneic bone marrow transplantation for high risk non-Hodgkin's lymphoma during first complete remission Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy? Stage II large B-cell lymphoma with sclerosis treated with MACOP-B Management of high-grade non-Hodgkin's lymphoma in adults. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL). The non-Hodgkin's lymphomas: pathology, staging, treatment Toxicity and preliminary results with a new eight-drug regimen (CEOP-IMVP-DEXA) in the treatment of aggressive lymphomas A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party Clinical studies of ABMT in non-Hodgkin's lymphoma. Malignant lymphoma in the elderly Non-Hodgkin's lymphoma in Saudi Arabia: prognostic factors and an analysis of the outcome of combination chemotherapy only, for both localized and advanced disease Alternated Versus Syncopated CHOP-PVB: Two Studies for the Treatment of Non-Hodgkin's Lymphoma by the Southwest Oncology Group Multicentre combined chemotherapy protocol for large cell advanced non hodgkin's lymphoma Heterogeneity of response and survival in diffuse histiocytic lymphoma after BACOP therapy (bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone). The management of adult aggressive non-Hodgkin's lymphomas Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, Potentially curable neoplasms Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study. A new approach to the treatment of advanced high-grade non-Hodgkin's lymphoma--intensive two-phase chemotherapy. MACOP-B chemotherapy for the treatment of high grade and intermediate grade non Hodgkin's lymphoma CHOP-firstline treatment in NHL with unfavorable prognosis--evaluation of therapeutic response and factors influencing prognosis CAVBP/DEP alternating chemotherapy for the treatment of intermediate and high grade non Hodgkin's lymphoma: final results of a pilot study Current status and perspectives in the treatment of non-Hodgkin's lymphomas Non-Hodgkin's lymphoma
is cites work of	wds:Q36467147-5E761CE5-54EA-4D78-AD37-3E9956CA962C wds:Q39600801-9B017A2A-104A-47D8-B514-E871AB2F39E7 wds:Q41866545-A093A77A-2E95-4D83-886F-186E2B417078 wds:Q69030181-AA078C60-79A5-4CA9-8F0D-15C18CE22FB5 wds:Q67705470-0FE9A24C-E0BB-49E5-AA1D-8A32A471936A wds:Q33947865-100D79EC-E73E-40D0-BDB2-68B838DB910E wds:Q45051134-649C64DF-555C-48AA-8D32-92FB40C8FABA wds:Q54721300-441C5F66-D6A8-4F2D-BCA9-0BDB764981AD wds:Q39673601-D76D1361-6254-40C2-887D-F4A91FA284B9 wds:Q54390463-A651285F-C99C-4B01-BB40-6E447FF6383C wds:Q70332901-6DF7A455-E009-452D-8509-5CFF556D995E wds:Q39696922-FCEEEB09-9C37-4144-A800-72601D40E2EF wds:Q41140588-7007919C-B262-42E7-A83E-E19E015F99E3 wds:Q45235393-F9A998E0-8471-4D16-A727-DC52A5068566 wds:Q67653328-57CC8F9C-4571-4BAB-8FF5-1AC4D14D58DA wds:Q73356031-16441064-84F1-49E2-8568-66F01ED96496 wds:Q67682069-F4E5E10B-A5A7-4797-A9C6-A862CEEA353C wds:Q69487453-71EB846B-83C5-4FE3-9F30-8BC01EC51B41 wds:Q35977407-2ACC4541-2C2A-4253-99C4-CEBD9BE5DFC8

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software